The estimated Net Worth of Dale Danilewitz is at least $2.3 Million dollars as of 23 May 2019. Dale Danilewitz owns over 543 units of Amerisource Bergen stock worth over $195,278 and over the last 10 years Dale sold ABC stock worth over $2,102,352.
Dale has made over 30 trades of the Amerisource Bergen stock since 2015, according to the Form 4 filled with the SEC. Most recently Dale sold 543 units of ABC stock worth $44,070 on 23 May 2019.
The largest trade Dale's ever made was exercising 21,500 units of Amerisource Bergen stock on 16 February 2018 worth over $781,955. On average, Dale trades about 2,797 units every 37 days since 2015. As of 23 May 2019 Dale still owns at least 1,085 units of Amerisource Bergen stock.
You can see the complete history of Dale Danilewitz stock trades at the bottom of the page.
Dale's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19087.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg, and Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: